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Investigating optimum sample preparation for
infrared spectroscopic serum diagnostics
Lila Lovergne,ab Graeme Clemens,a Vale´rie Untereiner,bc Roman A. Lukaszweski,d
Ganesh D. Sockalingum†b and Matthew J. Baker†*a
Bioﬂuids, such as serum and plasma, represent an ideal medium for the diagnosis of disease due to their
ease of collection, that can be performed worldwide, and their fundamental involvement in human
function. The ability to diagnose disease rapidly with high sensitivity and speciﬁcity is essential to exploit
advances in new treatments, in addition the ability to rapidly proﬁle disease without the need for large
scale medical equipment (e.g. MRI, CT) would enable closer patient monitoring with reductions in
mortality and morbidity. Due to these reasons vibrational spectroscopy has been investigated as a
diagnostic tool and has shown great promise for serum spectroscopic diagnostics. However, the
optimum sample preparation, optimum sampling mode and the eﬀect of sample preparation on the
serum spectrum are unknown. This paper examines repeatability and reproducibility of attenuated total
reﬂection (ATR) compared to transmission sampling modes and their associated serum sample
preparation with spectral standard deviation of 0.0015 (post pre-processing) achievable for both
sampling modes proving the collection of robust spectra. In addition this paper investigates the optimum
serum sample dilution factor for use in high throughput transmission mode analysis with a 3-fold dilution
proving optimum and shows the use of ATR and transmission mode spectroscopy to illuminate similar
discriminatory diﬀerences in a patient study. These fundamental studies provide proof of robust spectral
collection that will be required to enable clinical translation of serum spectroscopic diagnostics.
Introduction
Rapid detection of diseases enables the early administration of
a therapeutic strategy when the treatment is most eﬀective, thus
saving health expenditure and lives. For this purpose Fourier
Transform Infrared (FTIR) spectroscopy is a suitable technique
as it is non-destructive, label-free, rapid, cost-eﬀective, easy to
operate and requires simple sample preparation. Moreover, the
use of serum spectroscopy for diagnostics has the advantage for
patients to be relatively non-invasive compared to current
diagnostic methodologies such as biopsies.
Over the past few years many studies have shown the
successful use of vibrational spectroscopy for the analysis of
biological samples.1,2 Recent studies have investigated the
potential of vibrational spectroscopy as a diagnostic tool for
the analysis of biouids. A pilot study on saliva using FTIR
spectroscopy associated with linear discriminant analysis
(LDA), has reported the correct classication of diabetic
patients from healthy control (overall accuracy of 100% on
the training set and 88.2% on the validation test).3 The
potential of human tears for the diagnosis of ocular diseases
has been evaluated in preliminary studies, Travo et al. have
shown signicant discrimination (p < 0.0001) of healthy
people from patients with keratoconus (degenerative
disorder aﬀecting the cornea) and also between patients at an
early or advanced stage of disease by high throughput (HT)-
FTIR and principal component analysis (PCA).4–6 A study on
synovial uid by Raman spectroscopy and k-means analysis,
has shown the discrimination of patients with osteoarthritis
of low or high severity (74% sensitivity and 71% selectivity).7
Bile patient samples with malignant biliary strictures were
diﬀerentiated from samples of patients with benign biliary
diseases (sensitivity between 82% and 95%, specicity
between 85% and 100%) by HT-FTIR spectroscopy in asso-
ciation with support vector machine (SVM) classication and
leave-one-out cross validation (LOOCV).8 A Raman analysis
combined with PCA and quadratic discriminant analysis
(QDA) performed on urine has allowed the discrimination of
patients suﬀering from diabetes mellitus and hypertension
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with low, high risk of kidney failure or with kidney failure
(under dialysis) with a 70% overall classication rate (89%
for the control group and 81% for both high risk and renal
failure groups).9 However, the most popular biouids ana-
lysed by vibrational spectroscopy are blood-derived products
such as plasma10–14 and serum.15–18 Proof-of-principle studies
have shown the ability of FTIR spectroscopy to identify
diﬀerent types of cancer from serum samples. HT-FTIR
spectroscopy in transmission mode, was used to discriminate
urinary bladder cancer patients from patients with urinary
tract infection with an accuracy between 85 and 92% ach-
ieved with LDA or random forest (RF) classier,19 breast
cancer from healthy donors with 96% sensitivity and 93%
specicity with cluster analysis,20 cirrhotic patients with or
without hepatocellular carcinoma with 87% sensitivity and
85% specicity by SVM-LOOCV.21 Studies using attenuated
total reection (ATR)-FTIR spectroscopy, coupled with clas-
sication machine analysis obtained an accuracy of 95% and
82% for the discrimination of ovarian and endometrial
cancer22 and allowed to achieve 87.5% sensitivity and 100%
specicity for the diﬀerentiation of glioblastoma multiforme
(GBM) versus healthy control as well as on average of 94%
sensitivity and 96.5% specicity for the diagnosis of low
grade gliomas, GBM and healthy control.23,24
Vibrational spectroscopy provides information on the
composition and structure of matter. The principle of IR
spectroscopy is based on the interaction of IR light with
matter. Molecular bonds absorb the IR radiation at the
resonant frequency of the bond or group, exciting vibrational
modes. The resultant spectrum is a biochemical ngerprint
of the analysed sample, each absorption peak/band corre-
sponds to a specic vibration or combination of vibrations of
a molecular bond. This absorption phenomenon obeys the
Beer–Lambert law, thus allowing to obtain both quantitative
and qualitative information.25 In order to realise the full
potential of IR spectroscopy as a leading healthcare tool,
some issues need to be understood prior to clinical trans-
lation.26 One issue in particular related to biouid spectros-
copy is due to the strong IR activity of water. As such, the
most common protocol for analysing liquids such as bio-
uids is the drying of drop deposits. However, it has been
shown by optical and spectroscopic assessment that this
deposition is not homogenous.27–31 Thus, reproducibility and
reliability of drop-dried spectroscopic results are still ques-
tioned. This is even more pronounced when using micro-
spectroscopy. In addition, when analysing biouids with IR
transmission mode it is common to dilute the sample, due to
saturation of spectral peaks, with water prior to drying. The
eﬀect upon the spectrum and the optimum dilution is
unknown and has not been previously investigated. In order
to take full advantage of the potential of biouid spectros-
copy to provide a rapid and responsive diagnostic environ-
ment, this study reports the use of HT-FTIR, FTIR imaging
and ATR-FTIR to investigate and understand the eﬀect of
sample preparation upon the IR spectrum and provide an
optimum sample preparation for biouid spectroscopy.
Materials and methods
Serum samples
Normal human mixed pooled serum purchased from TCS
Biosciences (UK) were used for dilution tests. Serum samples
(n ¼ 105) from 70 patients needing high risk surgery (e.g. liver
and renal surgery, lung resection, large bowel resection,
gastrectomy, Whipple's procedure) were provided by the
Defence Science & Technology Laboratory (Dstl) Porton Down.
The study has been approved by Southampton & South West
Hampshire Research Ethics Committee (A), 1st Floor, Regents
Park Surgery, Shirley, Southampton, Hants, SO16 4RJ (refer-
ence number 06/Q1702/152). A consent form was signed by all
patients recruited into the study at the medical care centres
involved (Liverpool Royal and University Hospital, University
College Hospital, London, Bristol Royal Inrmary, Guy's & St
Thomas' Hospital, London, Birmingham Queen Elizabeth
Hospital and University Hospital, Frankfurt). Clotted blood
samples (4 mL) were centrifuged and the extracted serum
samples were stored at 80 C until needed for analysis. The
sera collected include 35 pre-operative samples, 35 post-
operative samples from the same patients the day following
surgery and 35 additional pre-operative samples from diﬀerent
patients. The study included 35 males and 32 females (the
gender of 3 patients from records were not provided) between
21 and 79 years old with an average age of 60 years.
Sample preparation for HT-FTIR and FTIR imaging
Four dilutions (1/2, 1/3, 1/4, 1/5) were performed on normal
pooled serum with physiological water (NaCl 0.9%, same
salinity as blood and used for intravenous injection and
dilution of drugs purchased from B. Braun, France). Five
microliters per replicate and 10 replicates per sample
including diluted, non-diluted normal serum and physiolog-
ical water as control, were pipetted onto each well of a silicon
plate (384 wells). Drops were dried at room temperature before
the spectral data acquisition. Serum samples from patients
were 3-fold diluted and 8 replicates were prepared using the
same protocol.
Infrared spectroscopy and imaging
Spectra of diluted, non-diluted pooled serum, physiological
water (30 spectra per condition, 180 spectra in total) and patient
serum samples (840 spectra in total) were collected with a high-
throughput screening HTS-XT extension coupled to a Tensor
27 spectrometer (both from Bruker Optics GmbH, Ettlingen,
Germany). Spectral acquisition was performed in the trans-
missionmode, controlled viaOPUS v6.5 soware (Bruker Optics
GmbH, Ettlingen, Germany) and collected at a spectral resolu-
tion of 4 cm1, co-adding 32 scans over the spectral range of
4000–400 cm1. A background spectrum was acquired before
each sample measurement and automatically removed from
sample spectra. One spectrum is obtained over the whole
surface of a well (4 mm diameter) of the 384 well silicon plate
used in the HTS-XT extension.
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To study the drop heterogeneity, spectral images of the
diluted serum drops were acquired with a PerkinElmer Spec-
trum Spotlight 400 imaging system (Courtaboeuf, France).
Three spectral images were performed on non-diluted, diluted
pooled serum and physiological water (18 spectral images in
total) at a spatial resolution of 25 mm per pixel, a spectral
resolution of 4 cm1, 8 co-added scans, and covering the spec-
tral range of 4000–750 cm1 (Spectrum-Image soware, version
1.6, PerkinElmer).
Patient serum sample spectra were also collected using a
Cary 600 series FTIR spectrometer from Agilent technologies,
USA, equipped with a Pike Miracle ATR Accessory. Aer thaw-
ing, 1 mL of each sample was pipetted onto a germanium (Ge)
crystal and dried for 8 minutes at room temperature. Three
spectra were collected per biological replicate and 3 replicates
performed for each sample (9 spectra per patient sample and
945 spectra for all samples in total). Spectra were acquired at a
resolution of 4 cm1, over the spectral range of 4000–400 cm1
and averaged over 32 co-added scans (Agilent soware, Agilent
technologies, USA). A background absorption spectrum of the
crystal was measured for atmospheric correction before each
replicate sample analysis and removed automatically from every
sample spectrum. One average spectrum is obtained over the
whole surface of the ATR crystal in contact with a sample. The
crystal was washed between each replicate analysis. Experi-
mental processes are detailed in the experimental schematic
shown in Fig. 1.
Pre-processing and data analysis
A quality test as previously described21 was performed on raw
spectra to control absorbance intensity, signal-to-noise ratio
and water vapour content (OPUS v6.5 soware, Bruker Optics
GmbH, Ettlingen, Germany). Spectra with a maximum absor-
bance higher than 1.8 or lower than 0.35 in arbitrary units (a.u.)
were rejected. Signal-to-noise ratio was calculated taking the
maximum absorbance of the Amide I band between 1700 and
1600 cm1 (S1) and between 1260 and 1170 cm1 (S2) respec-
tively divided by the noise intensity evaluated between 2100–
2000 cm1 (N). Spectra were rejected when S1/Nwas less than 50
and S2/N was less than 10. Water vapour content (W) was eval-
uated between the 1847–1837 cm1. Spectra were rejected when
S1/W was less than 20 and S2/W was less than 4.
Following the quality test, data reproducibility was assessed
on both raw and pre-processed spectra of diluted normal pooled
serum via a variance study which consists in calculating the
mean spectrum and the standard deviation (STD) for each
sample dilution condition (Fig. 3). Pre-processing of HT-FTIR
serum dilution test spectra was performed with OPUS v6.5
soware (Bruker Optics GmbH, Ettlingen, Germany). Spectra
were cut to the spectral range of 4000–900 cm1, base-line
corrected and vector normalised.
Spectral images of serum drops were rst subjected to an
atmospheric correction for water vapour and CO2 by the built-in
Spectrum-Image soware V1.6 (PerkinElmer, Courtaboeuf,
France) of the Spotlight 400 imaging system. Spectral images
were then reconstructed, based on a specic chosen single
Fig. 1 Schematic methodology representation. (A) Dilution test study performed on human pooled serum by high throughput-Fourier transform
infrared (HT-FTIR) spectroscopy and FTIR imaging. (B) HT-FTIR and total attenuated reﬂection (ATR)-FTIR spectroscopy comparison study
performed on pre- (n ¼ 70) and post- (n ¼ 35) surgery patient serum samples. Ge: germanium.
This journal is © The Royal Society of Chemistry 2015 Anal. Methods
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wavenumber in order to study the wavenumber-related
component distribution within drops (Spectrum-Image V1.6).
HT-FTIR and ATR-FTIR patient data pre-processing and
multivariate analysis were realised with Matlab soware version
7.11.0 (The Math Works, Inc., USA). All spectra were cut to the
spectral range of 1800–900 cm1 (ngerprint region). A prin-
cipal component based noise reduction using the rst 30
principal components (PCs) of the data was performed on the
spectra to improve the signal-to-noise ratio. All spectra were
then base-line corrected and vector normalised. Principal
Component-Discriminant Function Analysis (PC-DFA) was per-
formed on pre-processed data over the spectral region of
1200–950 cm1.
Results and discussion
Serum dilution eﬀect
Four dilutions (2-fold, 3-fold, 4-fold and 5-fold) of serum
samples were prepared with physiological water in order to
determine the most appropriate dilution for spectral acquisi-
tion with HT-FTIR spectroscopy as resulting spectra of non-
diluted serum samples were saturated (Fig. 2) at the protein
Amide I and Amide II bands (1700–1500 cm1) and H–O–H
stretching band at 3280 cm1. In the 2-fold dilution sample
group, 60% of the raw spectra failed the quality test, mainly due
to a high maximum absorbance (>1.8 a.u.) observed in the
Amide I band. On the contrary with a 5-fold dilution, 10% of the
spectra were rejected because of a too low maximum absor-
bance (<0.35 a.u.) of the Amide I band. With the 3- and 4-fold
dilution, all spectra passed the quality test with a maximum
absorbance of 1.6 and 0.9 respectively.
A variance study on both raw spectra and pre-processed
spectra was carried out on the spectra that passed the quality
test. Standard deviations (STD) of spectra from each dilution
(raw and pre-processed) are reported in Table 1. Pre-processed
spectra presented a lowest average STD compared to their cor-
responding raw data (Fig. 3). The pre-processing has improved
the reproducibility of the spectra. The 2-fold diluted pre-pro-
cessed spectra showed the lowest average STD due to the low
number of remaining spectra aer the quality test (40%). The
5-fold diluted pre-processed spectra presented the highest
average STD (0.0022). The STD results of the 3 and 4 fold dilu-
tion are similar with both providing low average STD aer pre-
processing (0.0012 and 0.0013 respectively). Globally, the
results show a good reproducibility of the spectra, similar to the
reproducibility of human pooled serum spectra reported by
Hands et al. via ATR-FTIR spectroscopy (average STD of 0.0137
and 0.0015 for raw and pre-processed spectra respectively).24
Combining the quality test and the variance study results,
the 3-fold dilution was determined as the most suitable dilution
for a serum HT-FTIR analysis with a good reproducibility and
absorbance intensity. The 3-fold dilution was chosen as a higher
dilution (e.g. 4-fold) will induce the risk of a low spectral
response, especially for the analysis of molecules present at a
low concentration within the serum. No molecular changes
were visible on collected spectra, assuming that there was no
eﬀect of the dilution with water on the composition of the
serum. Similar observations have been reported in a study by
Raman spectroscopy on plasma dilution tests. They concluded
that the plasma dilution did not aﬀect the chemical composi-
tion and molecular structure of proteins within dried drops.30
Spectral images were acquired to better understand the
distribution of serum molecular components within dried
drops as physical diﬀerences were observed between non-
diluted (presence of cracks) and diluted serum samples (hollow
shape) suggesting a drop composition heterogeneity (white
light images Fig. 4). It can be seen on the total absorbance
spectral image of the droplets that the absorbance intensity
varies within the same drop, with a highest absorbance inten-
sity in the drop edge compared to the centre. This translates as a
concentration gradient of serum components from the centre to
the periphery of the drops, showing an uneven drying process
across the serum droplets. As expected a global absorbance
Table 1 Quality test and variance study results performed on HT-FTIR spectra of normal pooled serum with diﬀerent dilutions
Dilution
Right spectra aer
quality test (%)
Mean STD
(raw spectra)
Mean STD
(pre-processed spectra)
1/2 40 0.015 0.0004
1/3 100 0.0474 0.0012
1/4 100 0.02 0.0013
1/5 90 0.0342 0.0022
Fig. 2 HT-FTIR raw spectra of non-diluted human pooled serum
(blue), diluted samples (2-fold: green; 3-fold: red; 4-fold: cyan; 5-fold:
black) and physiological water as negative control (pink).
Anal. Methods This journal is © The Royal Society of Chemistry 2015
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intensity decrease was observed for diluted samples compared
to non-diluted samples (total absorbance spectral images
Fig. 4). Spectral images based on a single wavenumber recon-
struction enabled the determination, within a drop, of the
distribution of molecules associated with the targeted peak. It
was observed (reconstructed spectral images Fig. 4) that serum
components such as proteins (Amide I and Amide II bands
around 1647 cm1 and 1542 cm1), lipids (1442 cm1) and
nucleic acids (1078 cm1) have a tendency to migrate towards
the periphery of the drops. This phenomenon is referenced in
the literature as the well-known coﬀee-ring eﬀect.32–34 This eﬀect
was more visible when the dilution factor increased, the ring
appearing thinner at the drops' edges and the centres appearing
more hollowed compared to non-diluted serum samples (white
Fig. 3 Variance study performed on HT-FTIR raw (A–D) and pre-processed (E–H) mean spectra (black) of diluted human pooled serum.
Standard deviation is represented in grey.
This journal is © The Royal Society of Chemistry 2015 Anal. Methods
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light images Fig. 4). The deposit and the resulting drop
morphology has also been shown to be inuenced by the
substrate hydrophobicity but without impact on the chemical
composition of samples.30 To avoid the coﬀee-ring eﬀect, a
study has recommended to perform an analysis on a lm
composed of reduced-size drops (217 drops of 200 pL each per
Fig. 4 Serum dilution study by FTIR imaging of dried drops. Original spectral images were atmospheric corrected. Other spectral images were
reconstructed on a single wavenumber. Abs: absorbance.
Anal. Methods This journal is © The Royal Society of Chemistry 2015
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well of a 384 wells silicon plate) obtained by an automatic
sampling and by controlling the drying process (vacuum
drying). They obtained a higher reproducibility of spectral data
compared to a non-automatic sampling.35
The presence of cracks has been observed on non-diluted
sample drops and was less visible/absent on diluted samples
(white light images Fig. 4). It has been reported that spectra
acquired from sample areas containing cracks suﬀer from
Fig. 5 ATR-FTIR and HT-FTIR comparison study on pre and post-surgery serum samples. (A and D) ATR-FTIR (A) and HT-FTIR (D) pre-processed
mean spectra of patient serum prior to surgery in red and after surgery in blue. (B and E) ATR-FTIR (B) and HT-FTIR (E) PC-DFA scatter plot, pre-
processed serum spectra of patients prior to surgery are represented by red triangles and after surgery by blue triangles over the spectral range of
950–1200 cm1 with their respective 90% conﬁdence ellipses. (C and F) ATR-FTIR (C) and HT-FTIR (F) corresponding DF1 loading from whole
patient serum. (G) ATR-FTIR and HT-FTIR spectra (from A and D) in green and red respectively.
This journal is © The Royal Society of Chemistry 2015 Anal. Methods
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spectral distortions resulting in an abnormal Amide I and II
bands and baseline.29 In this study, the dilution of the serum
samples has provided visually a dried drop with greater
homogeneity over the surface. Moreover, one averaged spec-
trum is acquired on the whole surface of a well with the
HT-FTIR technique, resulting in a representative spectrum of
the entire serum sample contrary to spectra collected in a single
point mode as serum dried drops spectra have shown spatial
but also chemical heterogeneity.28
ATR-FTIR and HT-FTIR spectroscopy comparison
An analysis was carried out on pre- and post-operative serum
samples from patients having undergone surgery for diﬀerent
clinical reasons. This set of samples (n ¼ 105) was used to
compare the two techniques ATR-FTIR and HT-FTIR spectros-
copy and also to enable the proling of a baseline IR response
when considering only surgery. ATR-FTIR is an excellent tech-
nique for the analysis of serum since a sample can be directly
deposited and dried on the ATR crystal before the spectral
acquisition.36However, there are currently no multi-well sample
accessories to enable rapid automated collection of spectra.
HT-FTIR enables the rapid automated collection of spectra but
there is an increased requirement for further sample prepara-
tion via sample dilution. As such it takes 6 hours to collect
360 spectra from 360 samples on a multi-well plate via HT-FTIR
spectroscopy and in the same amount of time 40 spectra would
have been able to be collected via the current ATR-FTIR
approach (the addition sample preparation time for the HT-
FTIR takes approximately 1 hour for the deposit of 360 samples
and 30 minutes for the samples drying). The sample prepara-
tion regarding the analysis of serum by ATR-FTIR has been
reproduced from the methodology applied by Hands et al.24
They have determined that a serum drop of 1 mL is dry aer
8 minutes at room temperature and that the resultant spectra
acquired exhibited a high reproducibility. In the present study,
spectra from human serum samples were collected from 1 mL
and 5 mL (3-fold diluted serum) for the ATR-FTIR and HT-FTIR
spectroscopy respectively. These spectra were reproducible and
repeatable thus conserving the serum resource by using minute
amounts. Spectral diﬀerences are visible on the average spectra
of the two pre- and post-operative sample groups especially
between 950 and 1200 cm1 for both ATR-FTIR and HT-FTIR
techniques, further diﬀerences are discernable between
1250 and 1700 cm1 but only with the ATR-FTIR method
(Fig. 5A and D). A diﬀerent ratio and a peak shi is observable
for the Amide I and Amide II peaks between ATR and trans-
mission sampling modes (Fig. 5A, D and 5G). This is similar to
the ratio and peak shi diﬀerences observed by Ollesch et al.35
on dried serum sample comparison between ATR and trans-
mission due to dispersion eﬀects. Associated with PC-DFA, both
ATR-FTIR and HT-FTIR spectroscopies show similar scores
plots and discriminatory ability to separate serum spectra over
the range of 1200–950 cm1 of patients prior to surgery and
serum spectra aer surgery in spite of similarities resulting in
an overlap. Discriminant Function 1 (DF1) in both cases is
responsible for the separation of the two spectral groups
(Fig. 5B and E) and DFs along the y-axes are only shown for
visual purposes. Loadings on DF1 contain only the spectral
information that is responsible for the discrimination between
spectral groups (Fig. 5C and F). With both techniques, the same
peaks have been identied but have opposite directions on the
loadings plots. Positive peaks in DF1 loadings for the ATR-FTIR
spectroscopy analysis are negative in the DF1 loadings for the
HT-FTIR spectroscopy study and vice versa. Spectra from the two
groups are also separated in an inverse way against the x-axis of
the scatter plots between the two techniques. Proposed peaks
assignments are presented in Table 2. Major peaks of the
loadings on DF1 were in both cases 1040–1023 cm1 corre-
sponding to glycogen and 1078 cm1 assigned as C–O stretch
(DNA/RNA). It can be noted that a complete separation of the
two groups by PC-DFA was not expected since it is known that a
surgical procedure triggered physiological and immunological
reactions in order to maintain the body homeostasis but the
stress induced by surgery and the associated body responses are
dependent of many factors such as the kind of procedure and its
relative injury severity, pre-existing pathologies, genetic
predisposition of patients and the diﬀerence observed will not
be as signicant as diseased versus non-diseased patient
samples.37–39
Conclusion
HT-FTIR and ATR-FTIR techniques have both shown promising
results for serum dried-drops analysis with a high reproduc-
ibility of the spectra collected on normal human pooled mixed
serum samples. Moreover, both approaches associated with
multivariate analysis have shown an equivalent capability to
distinguish spectra of patient serum collected before and aer
surgical procedures. This basal IR response to surgery should be
taken into consideration when performing a diagnostic study as
molecular changes observed in spectra might be due to the
surgery/inammation itself and not to the pathology targeted,
however this study has shown that these responses are not
signicant enough to enable full diﬀerentiation of serum
samples. Compared to the HT-FTIR technique where serum
samples have to be diluted because of a saturation eﬀect, with
Table 2 HT-FTIR and ATR-FTIR PC 1 loading peaks
assignments1,23,24,40,41
Frequency (cm1) Assignments
1170 Ester C–O asymmetric stretch
1150 C–O stretch (carbohydrates)
1125 C–C asymmetric stretch
1110 CN stretch, CH bend
1100 PO2
 symmetric stretch (nucleic acid)
1078 C–O stretch (deoxyribose/DNA–RNA)
1065 Chain C–C
1050 C–O stretch
1023–1040 Glycogen
1006 Phenylalanine (ring breathing)
990 CO–O–C stretch
970 C–C, CN stretch, PO3
2 stretch (DNA)
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the ATR-FTIR method, samples can be directly applied onto the
ATR crystal and can be portable. However, this implies no
possible sample storage for further analysis as the crystal has to
be cleaned aer each sample measurement and no automation
of the analysis is yet available. Regarding these aspects, with the
HT-FTIR technique the storage of samples is in theory feasible
but no studies have investigated the eﬀect of the conservation
over the time of serum properties integrity. A 3-fold dilution was
shown to be optimum based upon a variance study, quality test
and the ability to detect low concentration biochemicals present
compared to higher dilutions and is the recommendation for
HT-FTIR analysis. HT-FTIR spectroscopy has the advantage to
allow an automated analysis that is an important criterion for a
transposition of IR spectroscopy into a clinical application. This
automation advantage can be seen in the time comparison with
HT-FTIR being able to collect 360 spectra, in the same time it
would allow to collect 40 spectra in the current ATR-FTIR
approach. An automated approach for ATR-FTIR analysis would
be benecial as there is a comparable spectral reproducibility
between ATR-FTIR and HT-FTIR spectroscopy and a comparable
ability to discriminate and illuminate diﬀerences in patient
spectra but with an automated ATR-FTIR approach, there would
not be a need for dilution.
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